Back to mobile site

Nymox Pharma (NYMX) Ramps to Session Highs Following Fexapotide Phase 3 Data

August 24, 2016 3:05 PM EDT Send to a Friend
Nymox Pharma (Nasdaq: NYMX) shares are trading to session highs. The stock ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login